Today: 21 March 2026
Subscribe
Browse Category

Share Buybacks 16 December 2025 - 6 January 2026

Waste Management (WM) Stock News on Dec. 24, 2025: Institutional Buys, Employee Trading Blackout, and a 2026 Dividend-and-Buyback Push

Waste Management (WM) Stock News on Dec. 24, 2025: Institutional Buys, Employee Trading Blackout, and a 2026 Dividend-and-Buyback Push

WM disclosed increased institutional ownership on Dec. 24, with Vontobel Holding and Swedbank AB reporting large Q3 stake boosts. A retirement-plan trading blackout begins today as the company changes recordkeepers. Investors continue to watch WM’s integration of Stericycle’s medical waste unit and upcoming $3 billion buyback and dividend increase planned for 2026.
24 December 2025
··
DCC Plc Stock Update (24 Dec 2025): £600m Tender Offer Buyback Completed, FTSE Index Changes Take Effect, and Analysts Forecast Upside

DCC Plc Stock Update (24 Dec 2025): £600m Tender Offer Buyback Completed, FTSE Index Changes Take Effect, and Analysts Forecast Upside

DCC Plc completed a £600 million tender offer buyback, cancelling about 12% of its issued share capital. FTSE Russell’s index updates reflecting the new share count took effect at the open on 24 December 2025. DCC shares traded at 4,726.00p, down 0.21% as of 08:17 GMT, with delayed intraday pricing. The tender offer strike price was £51.70 per share.
24 December 2025
··
Shell Plc Stock News Today (Dec. 24, 2025): Buyback Update, Q4 Results Date, Analyst Forecasts, and What Investors Are Watching

Shell Plc Stock News Today (Dec. 24, 2025): Buyback Update, Q4 Results Date, Analyst Forecasts, and What Investors Are Watching

Shell reported new share buybacks on Dec. 23, purchasing 730,152 shares in London and 726,004 in Amsterdam for cancellation as part of its ongoing $3.5 billion repurchase program. The company’s U.S. shares closed at $73.07 and London shares at 2,702.00 GBp on Dec. 23. Shell’s next major update is scheduled for Jan. 8, 2026, with full Q4 results and dividend details due Feb. 5.
24 December 2025
····
RELX PLC Stock (LSE: REL, NYSE: RELX): Buyback Update, 2026 Results Date, and Fresh Analyst Forecasts (23 Dec 2025)

RELX PLC Stock (LSE: REL, NYSE: RELX): Buyback Update, 2026 Results Date, and Fresh Analyst Forecasts (23 Dec 2025)

RELX PLC completed its 2025 share buyback, purchasing 39.5 million shares for £1.5 billion, and announced a new £250 million buyback to run from 2 January to 6 February 2026. The company cancelled 55 million treasury shares, leaving 1.82 billion shares outstanding. RELX shares last traded at 3,046p in London and $40–$41 on the NYSE ADR line.
23 December 2025
·····
Standard Chartered PLC Stock (LSE: STAN) on 22 Dec 2025: Buyback Nears $1B, Blockchain Treasury Push, and Diverging 2026 Price Targets

Standard Chartered PLC Stock (LSE: STAN) on 22 Dec 2025: Buyback Nears $1B, Blockchain Treasury Push, and Diverging 2026 Price Targets

Standard Chartered closed near 1,792p in London on 22 December, close to its 52-week high, with a market cap of about £40.6bn. The bank disclosed it bought back 458,902 shares at an average 1,789.47p, bringing cumulative buybacks to roughly $996.4m. Shares in issue will drop to 2,265,711,794. The current buyback program is authorized up to $1.3bn through January 2026.
22 December 2025
···
DCC Plc Stock (LSE: DCC) Update on Dec. 22, 2025: £600m Tender Offer Buyback Completed, Shares Cancelled, and Analysts’ 2026 Outlook

DCC Plc Stock (LSE: DCC) Update on Dec. 22, 2025: £600m Tender Offer Buyback Completed, Shares Cancelled, and Analysts’ 2026 Outlook

DCC Plc completed a £600 million tender-offer buyback, purchasing and cancelling 11,605,415 shares—about 12% of its issued share capital—at £51.70 per share. The offer closed fully subscribed on 17 December 2025. DCC’s share count with voting rights now stands at 85,423,097. Shares traded around 4,914p on 22 December, below the buyback price.
22 December 2025
·
DBS Group Holdings Ltd Stock (SGX:D05) on Dec. 22, 2025: Near Record Highs as Dividends, Buybacks and RMB Clearing Role Drive the 2026 Debate

DBS Group Holdings Ltd Stock (SGX:D05) on Dec. 22, 2025: Near Record Highs as Dividends, Buybacks and RMB Clearing Role Drive the 2026 Debate

DBS shares traded near a record high at S$55.70 on Dec. 22, 2025, following a new peak of S$56 set on Dec. 16. The bank was appointed Singapore’s second renminbi clearing bank on Dec. 15, supporting its transaction-banking push. DBS holds a market cap of about S$158 billion, with a trailing P/E near 14 and a dividend yield of roughly 4.3%.
22 December 2025
···
Keppel Ltd Stock (SGX:BN4): Latest News, Share Buybacks, and Analyst Forecasts as of December 21, 2025

Keppel Ltd Stock (SGX:BN4): Latest News, Share Buybacks, and Analyst Forecasts as of December 21, 2025

Keppel Ltd sold its remaining stakes in two Singapore data centres to Keppel DC REIT for S$50.5 million, with completion expected by Q1 2026. The company has also bought back 50,000 shares daily from Dec 15–19, with prices near S$10.00–S$10.13 per share. Keppel says the data centre sale will not materially affect its current-year earnings or net asset value.
21 December 2025
··
Westpac Banking Corporation Stock (ASX: WBC) on 21 Dec 2025: Dividend Paid, Buyback Running, AGM Pressure — and Why Analysts Still Look Cautious

Westpac Banking Corporation Stock (ASX: WBC) on 21 Dec 2025: Dividend Paid, Buyback Running, AGM Pressure — and Why Analysts Still Look Cautious

Westpac shares closed at A$38.76 on 19 December 2025, up 20% for the year but below the A$41.00 high. The bank paid a fully franked 77-cent final dividend and resumed its on-market buyback, with A$2.485 billion spent so far. The buyback is set to continue into late 2026. At the AGM, a director was re-elected despite significant protest votes.
21 December 2025
···
DCC Plc Stock: £600m Tender Offer Buyback Cuts Share Count by 12% as Analysts Update Forecasts (Dec. 20, 2025)

DCC Plc Stock: £600m Tender Offer Buyback Cuts Share Count by 12% as Analysts Update Forecasts (Dec. 20, 2025)

DCC plc completed a £600 million tender offer, buying back 11.6 million shares at £51.70 each and cancelling about 12% of its issued share capital. The company’s voting shares now stand at 85,423,097. DCC shares closed at 4,976p on 19 December, up 1.22% with trading volume above 24 million. FTSE Russell will update DCC’s index share count on 24 December.
20 December 2025
···
FactSet (FDS) Stock Slides After Q1 FY2026 Earnings: Revenue Beat, Guidance Reaffirmed, and a $1 Billion Buyback — What Investors Are Watching (Dec. 18, 2025)

FactSet (FDS) Stock Slides After Q1 FY2026 Earnings: Revenue Beat, Guidance Reaffirmed, and a $1 Billion Buyback — What Investors Are Watching (Dec. 18, 2025)

FactSet shares fell about 7% to the mid-$270s on December 18 despite beating fiscal Q1 estimates with adjusted EPS of $4.51 and revenue of $607.6 million. The company reaffirmed guidance and expanded its buyback to $1 billion, but margins narrowed and organic subscription growth slowed, unsettling investors.
18 December 2025
···
Singtel Stock (SGX: Z74) News on 18 Dec 2025: Optus Outage Review, Dividend Support, Buyback Momentum, and Analyst Price Targets

Singtel Stock (SGX: Z74) News on 18 Dec 2025: Optus Outage Review, Dividend Support, Buyback Momentum, and Analyst Price Targets

Optus released an independent review into its September outage, finding major process and accountability gaps that led to 75% of emergency calls failing. Singtel shares traded near S$4.52 after the report, as investors weighed regulatory and operational risks against improving core profits and a higher interim dividend. Optus’ board accepted all 21 recommendations from the review and pledged quick action.
18 December 2025
··
Brambles Limited Stock (ASX:BXB) on 18 December 2025: Buyback Update, Share Count Moves, and Analyst Forecasts

Brambles Limited Stock (ASX:BXB) on 18 December 2025: Buyback Update, Share Count Moves, and Analyst Forecasts

Brambles Limited bought back 243,581 shares for A$5.57 million on 17 December, with cancellation set for 19 December. The company also issued 7,633 new shares under its employee plan. Brambles shares traded between A$22.595 and A$23.035 on Thursday. The ongoing buyback program allows for up to US$400 million in repurchases.
18 December 2025
···
Zoetis Stock (ZTS) News Today: $1.75B Convertible Notes, Accelerated Buybacks, Dividend Raise, and Analyst Forecasts (Dec. 17, 2025)

Zoetis Stock (ZTS) News Today: $1.75B Convertible Notes, Accelerated Buybacks, Dividend Raise, and Analyst Forecasts (Dec. 17, 2025)

Zoetis priced $1.75 billion in 0.25% convertible senior notes due 2029, with proceeds earmarked for share buybacks under its $6 billion repurchase program. Morgan Stanley cut its price target to $160 from $175, citing growth and competition concerns. Zoetis shares closed up 1.9% on Dec. 16 but remain far below early 2025 highs. The notes deal is set to close Dec. 18.
17 December 2025
··
Rolls-Royce (RR.L) Stock Update 16 December 2025: £200m Interim Buyback, Analyst Forecasts, and What Investors Are Watching Next

Rolls-Royce (RR.L) Stock Update 16 December 2025: £200m Interim Buyback, Analyst Forecasts, and What Investors Are Watching Next

Rolls-Royce announced a £200 million interim share buyback on Tuesday, following the completion of its £1 billion 2025 program in November. Shares traded down about 0.9% at £11.03 in early London trading. The new buyback will run from 2 January to 24 February 2026, with UBS AG London Branch as broker. Shares purchased will be cancelled, reducing share capital.
16 December 2025
··
1 … 7 8 9 10 11 … 14

Stock Market Today

  • Grail Shares Surge 12.4% After Analyst Upgrade Amid Trial Uncertainty
    March 21, 2026, 6:53 AM EDT. Shares of multi-cancer early detection company Grail jumped up to 12.4% this week following a Wall Street analyst's rating upgrade from "hold" to "buy." The new price target, however, was lowered to $65, still offering a 39% premium over the last close. This comes despite the company missing its primary endpoint in a key trial measuring stage III-IV cancer detection reductions with its Galleri test. The trial did show promising increases in early-stage cancer detection and reduced late-stage cases, which investors hope will be bolstered by upcoming follow-up data. Analyst TD Cowen cited potential for FDA approval and insurance coverage as reasons for optimism in a volatile healthcare stock environment.
Go toTop